rs137853319
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP6_Very_StrongBS1BS2
The NM_001110556.2(FLNA):c.3872C>T(p.Pro1291Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,209,459 control chromosomes in the GnomAD database, including 2 homozygotes. There are 80 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P1291P) has been classified as Likely benign.
Frequency
Consequence
NM_001110556.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FLNA | NM_001110556.2 | c.3872C>T | p.Pro1291Leu | missense_variant | 23/48 | ENST00000369850.10 | |
FLNA | NM_001456.4 | c.3872C>T | p.Pro1291Leu | missense_variant | 23/47 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FLNA | ENST00000369850.10 | c.3872C>T | p.Pro1291Leu | missense_variant | 23/48 | 1 | NM_001110556.2 |
Frequencies
GnomAD3 genomes ? AF: 0.000276 AC: 31AN: 112404Hom.: 0 Cov.: 24 AF XY: 0.000463 AC XY: 16AN XY: 34550
GnomAD3 exomes AF: 0.000271 AC: 49AN: 180492Hom.: 1 AF XY: 0.000356 AC XY: 24AN XY: 67370
GnomAD4 exome AF: 0.000130 AC: 143AN: 1097002Hom.: 2 Cov.: 33 AF XY: 0.000176 AC XY: 64AN XY: 362970
GnomAD4 genome ? AF: 0.000276 AC: 31AN: 112457Hom.: 0 Cov.: 24 AF XY: 0.000462 AC XY: 16AN XY: 34613
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 08, 2020 | This variant is associated with the following publications: (PMID: 16299064, 28133863, 23873601, 25167861, 17632775, 23871722) - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | FLNA: BP4, BS2 - |
FG syndrome 2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 15, 2007 | - - |
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 11, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Melnick-Needles syndrome;C0265293:Frontometaphyseal dysplasia;C1844696:Oto-palato-digital syndrome, type II;C1848213:Heterotopia, periventricular, X-linked dominant Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 15, 2024 | - - |
FLNA-related condition Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 12, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at